Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wharton's Jelly MSCs for Refractory Systemic Sclerosis With Pulmonary Involvement
NCT07542067Phase 2Completed
- Sponsor
- Fundación Neumológica Colombiana
- Start
- May 2024
- Primary completion
- Jun 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ProTrans in systemic sclerosis (SSc), pulmonary hypertension (PH), pulmonary fibrosis (PF), sponsored by Fundación Neumológica Colombiana. Started May 2024; status: completed.
02
Drugs
ProTrans
03
Conditions
systemic sclerosis (SSc)pulmonary hypertension (PH)pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT07542067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07542067.